Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiscoverIE Regulatory News (DSCV)

Share Price Information for DiscoverIE (DSCV)

Share Price is delayed by 15 minutes
Get Live Data
682.00    -3.00 (-0.44%)
Bid:
679.00
Ask:
682.00
Spread: 3.00 (0.442%)
Market Cap: £662.37m
DSCV Live PriceLast checked at - London Stock Exchange

Intraday DiscoverIE Share Chart

SEMICONDUCTOR CONTRACT TERMINATION

3 Feb 2009 07:00

RNS Number : 6727M
Acal PLC
03 February 2009
 



FOR RELEASE

7.00 AM

FEBRUARY 2009

ACAL plc 

SEMICONDUCTOR CONTRACT TERMINATION

Acal has been notified by one of its semiconductor suppliers to the electronics division that it is terminating Acal's distribution contract. Termination will take effect from 30 April 2009.

This product line represents approximately 4% of group revenue and 3% of gross margin.

As stated in our Interim Management Statement dated 23 January, we are carrying out a review of Acal's business and strategy and will factor this contract loss into the review.

For further information:-

Nicholas Jefferies ~ Chief Executive

Malcolm Cooper ~ Finance Director

Brian Coleman-Smith/James Verstringhe

Cubitt Consulting 

01483 544500

01483 544500

020 7367 5100

Notes to Editors:

Acal is a leading European value-added distributor providing specialist design-in, sales and marketing services for international suppliers in the fields of Electronic Components, Supply Chain Services and Medical and Scientific products. Organised into three divisions, Acal has 15 principal trading companies of which 8 are in Continental Europe and 7 in the UK.

Acal is now Europe's strongest multi-disciplined design-in electronics distributor and has always differentiated its offering with a strong focus on demand creation and a highly skilled technical sales force. Vertec Scientific, which operates in both the UK and South Africa, represents leading manufacturers in the field of bone densitometry, medical imaging and diagnostics. The Supply Chain division provides spare parts to field services organisations and is a supplier to virtually every leading company in that market.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCCKBKKBBKBABK
Date   Source Headline
5th Sep 20232:17 pmRNSNotification of Major Holdings
31st Aug 20237:00 amRNSAcquisition completion - Silvertel
1st Aug 20237:00 amRNSAcquisition of Silvertel
24th Jul 20232:31 pmRNSResults of Annual General Meeting
24th Jul 20237:00 amRNSTrading Update
27th Jun 202310:53 amRNSDirector / PDMR Shareholding
27th Jun 202310:47 amRNSNotification of Major Holdings
22nd Jun 202312:35 pmRNSAnnual Report & Notice of AGM
19th Jun 20238:35 amRNSNotification of Major Holdings
15th Jun 20239:51 amRNSDirector LTIP Award
7th Jun 20237:00 amRNSPreliminary results
1st Jun 20232:50 pmRNSNotification of Major Holdings
30th May 20237:00 amRNSAppointment of Non-Executive Director
18th May 20231:33 pmRNSNotification of Major Holdings
17th May 202310:25 amRNSNotice of Full Year Results
19th Apr 20237:00 amRNSFull Year Trading Update
18th Apr 20237:00 amRNSNotification of Major Holdings
29th Mar 20235:47 pmRNSNotification of Major Holdings
15th Mar 20233:53 pmRNSNotification of Major Holdings
15th Mar 20238:37 amRNSNotification of Major Holdings
15th Mar 20237:00 amRNSNotification of Major Holdings
23rd Feb 20232:58 pmRNSNotification of Major Holdings
20th Feb 20239:48 amRNSNotification of Major Holdings
15th Feb 20235:33 pmRNSNotification of Major Holdings
13th Feb 202311:36 amRNSNotification of Major Holdings
25th Jan 20237:00 amRNSQ3 Trading Update and Acquisition Completion
6th Jan 20231:41 pmRNSNotification of Major Holdings
6th Jan 20238:24 amRNSNotification of Major Holdings
3rd Jan 202310:38 amRNSNotification of Major Holdings
22nd Dec 20227:00 amRNSAcquisition of Magnasphere Corporation
14th Dec 20224:31 pmEQSParadigm Biopharmaceuticals (PAR): Adapted therapies to meet unmet demand
5th Dec 20229:53 amEQSdiscoverIE Group (DSCV): Focused on sustainable growth
2nd Dec 202212:58 pmRNSNotification of Major Holdings
2nd Dec 20228:37 amRNSNotification of Major Holdings
23rd Nov 202212:01 pmEQSdiscoverIE Group profits jump in 'very strong first half'
23rd Nov 20227:00 amRNSdiscoverIE Commits to Net Zero Emissions
23rd Nov 20227:00 amRNSInterim Results
21st Nov 20223:38 pmRNSNotification of Major Holdings
16th Nov 20228:58 amRNSTR-1: Notification of Major Holdings
14th Nov 20223:41 pmRNSIssue of Equity & Total Voting Rights
1st Nov 202212:08 pmRNSNotice of Half Year Results
1st Nov 20227:00 amRNSDirectorate Changes
14th Oct 20224:56 pmRNSNotification of Major Holdings
13th Oct 20223:31 pmRNSTR-1: Notification of major holdings
13th Oct 20227:00 amRNSFirst Half Trading Update
11th Oct 202211:42 amRNSNotification of Major Holdings
5th Oct 20227:52 amRNSNotification of Major Holdings
5th Oct 20227:52 amRNSNotification of Major Holdings
28th Sep 20227:36 amRNSDirector Declaration
2nd Sep 202210:26 amRNSNotification of Major Holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.